Comparison of Varying Bolus Doses of Oxytocin in Patients Undergoing Caesarean Spinal Delivery
DOI:
https://doi.org/10.51985/JBUMDC2020018Keywords:
Caesarean section, Maternal hemodynamics, Oxytocin, Phenylephrine, Uterine atony.Abstract
caesarean delivery avoiding side effects.
Study design and setting: A study was conducted at Rawal General and Dental Hospital, from 10th Oct, 2018 to 27th
May, 2019.
Methodology: Patients undergoing elective cesarean spinal delivery were randomly divided by computer generated
numbers(n=155) into 5 groups A, B, C, D and E receiving 0.5, 1, 3, 5 and 10 units of injection oxytocin as bolus respectively
after delivery of baby. Uterine contraction was assessed by gynecologist by manual palpation of uterus on a linear scale.
Value of 8 was considered adequate and 8 inadequate uterine tone respectively. Heart rate, non-invasive blood pressure
and oxygen saturation were noted before and after oxytocin bolus. All patients received oxytocin infusion. The primary
outcome measure was the assessment of uterine tone at 2 minute of oxytocin bolus. The secondary outcome variables
included shortness of breath, chest discomfort, top-up bolus administered, hemodynamic variables, epigastric discomfort
and oxytocin related effects (tachycardia, epigastric discomfort and hypotension).
Results: The use of 5 units oxytocin (group-D) showed most optimal uterine contractions, 61.3% in comparison to commonly
used 10 units bolus dose (group-E) 48.4% with minimal side effects like, less tachycardia(12.9% versus 72.9%) and
hypotension (12.9% versus 32.3%), no top-up bolus dose was required in 54.8% cases and no complain of epigastric
discomfort was observed.
Conclusion: Low doses of oxytocin are effective in terms of uterine contraction with minimal side effects.
References
REFERENCES:
Murphy DJ, Carey M , Montgomery AA , Sheehan SR . Study Protocol. ECSSIT - Elective Caesarean Section Syntocinon Infusion Trial. A multi-Centre Randomised Controlled Trial of Oxytocin (Syntocinon) 5 IU bolus and Placebo Infusion Versus Oxytocin 5 IU bolus and 40 IU Infusion for the Control of Blood Loss at Elective Caesarean Section. BMC Pregnancy Childbirth. 2009;9:36.
Kothari D, Bhalavi S, Gautam A, Choudhary B, Dahiya S, Pathak V. Effects of three doses of oxytocin (3, 5 ,10 I U) on haemodynamic parameters, uterine tone and blood loss in elective caesarean section under spinal anaesthesia. A prospective randomised double-blind study. J. Evolution Med. Dent. Sci. 2018:17(35);3913-3917.
Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage
of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988;95(1):3-16. 4. Carvalho Jose CA, Balki M, Kingdom J, Windrim R. Oxytocin Requirements at Elective Cesarean Delivery: A Dose-Finding Study. Obstet & Gynecol 2004;104:1005-10.
Svanstrom MC, Biber B, Hanes M, Johansson G, Naslund U, Balfors EM. Signs of Myocardial Ischaemia After Injection of Oxytocin: A Randomized Double-Blind Comparison of Oxytocin and Methylergometrine During Caesarean Section. Br J Anaesth 2008;100(5):683-9.
Pinder AJ, Dresner M, Calow C, Shorten GD, O’Riordan J, Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth 2002; 11:156– 9.
Edwards BR, LaRochelle Jr FT. Antidiuretic Effect of Endogenous Oxytocin in Dehydrated Brattleboro Homozygous
Rats. Am J Physiol 1984; 247:453-65.
Wedisinghe L, Macleod M, Murphy DJ. Use of Oxytocin to Prevent Haemorrhage at Caesarean Section- A Survey of
Practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 2008; 137:27-30.
Cunningham FG, MacDonald PC, Gant NF. Cesarean section and cesarean hysterectomy. In: Cunningham FG, MacDonald
PC, Gant NF, eds. Williams obstetrics. Norwalk: Appleton & Lange, 1989;441-59.
Kovacheva VP, Soens MA, Tsen LC. A Randomized, Doubleblinded Trial of a "Rule of Threes" Algorithm Versus
Continuous Infusion of Oxytocin During Elective Cesarean Delivery. Anesthesiology 2015; 123 (1):92-100.
Thomas TA, Cooper GM. Maternal Deaths from Anaesthesia. An Extract from Why Mothers Die 1997-1999, the Confidential
Enquiries Into Maternal Deaths in the United Kingdom. Br J Anaesth. 2002; 89: 499-508.
Ngan Kee WD. Prevention of Maternal Hypotension After Regional Anaesthesia for Caesarean Section. Curr Opin
Anaesthesiol 2010; 23 (3): 304 - 9.
Mohta M, Kumar V, Agarwal R, Chilkoti Geetanjali T, Duggal S. Efficacy of Phenylephrine in Preventing Hemodynamic
Responses of Oxytocin during Elective Cesarean Section: A Randomized, Double-Blind, Controlled Trial. Ann Natl Acad
Med Sci (India) 2019; 55(1):48-53.
Orbach-Zinger S, Einav S, Yona A, Eidelman LA, Fein S, Davis A, Loscovich A. A survey of physicians’ attitudes
toward uterotonic administration in parturients undergoing cesarean section. The Journal of Maternal-Fetal & Neonatal
Medicine 2018: 31(23); 3183-3190.15. Abbas A, Akram H, Farooq B. Comparison of hemodynamic
changes caused by 2 units versus 5 units of oxytocin during elective caesarean section under spinal anaesthesia. Esculapio
J Services Inst Med Sci Oct-Dec 2013;9(4):168-70.
Morgan GE, Mikhail MS. Clinical Anesthesiology. 5th Edition. Mc Graw Hill Education 2013; 18: 297.
Dyer RA, Farina Z, Joubert IA, Du Toit P, Meyer M, Torr G,Wells K, James MF. Crystalloid preload versus rapid
crystalloid administration after induction of spinal anaesthesia (coload) for elective caesarean section. Anaesth Intensive
Care 2004; 32:351–7.
Breen TW, Shapiro T, Glass B, Foster-Payne D, Oriol NE. Epidural anesthesia for labor in an ambulatory patient. Anesth
Analg 1993;77: 919-24.
Apgar V, Holaday DA, James LS, Weisbrot IM, Berrien C. Evaluation of the newborn infant; second report. J Am Med
Assoc. 1958; 168:1985-8.
Maqbool MS. Evaluation of Heart Rate Variability and Baroreflex Sensitivity in Cesarean Spinal Delivery. Med
Forum 2018;29(3):78-82.
Anya SU, Onyekwulu FA, Onuora EC. Comparison of visual estimation of intra-operative blood loss with haemoglobin
estimation in patients undergoing caesarean section. Niger Postgrad Med J 2019; 26:25-30.
Ashraf Aly H, Ramadani HM. Assessment of blood loss during cesarean section under general anesthesia and epidural
analgesia using different methods. Alexandria J Anaesth Intensive Care 2006; 9:25-34.
Sartain JB, Barry JJ, Howat PW, McCormack DI, Bryant M. Intravenous Oxytocin Bolus of 2 Units Is Superior to 5 Units
During Elective Caesarean Section. Br J Anesth 2008; 101:822-6.
Sheehan SR, Wedisinghe L, Macleod M, Murphy DJ, Implementation of Guidelines on Oxytocin Use at Caesarean
Section: A Survey of Practice in Great Britian and Ireland.
Eur J Obstet Gynecol Reprod Biol 2010; 148:121-4. 25. Stoelting RK. Pharmacology and Physiology in Anesthetic
Practice, 3rd ed. Lippincott Williams & Wilkins, USA 1999. https://doi.org/10.1097/00000542-200610000-00052
Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B. Minimum Effective Bolus Dose of Oxytocin During Elective
Caesarean Delivery. Br J Anaesth 2010; 104:338-43.
Qian XW, Drzymalski DM, Ly CC, Guo FH, Wang LY, Chen XY. The ED 50 and ED95 of Oxytocin Infusion Rate for
Maintaining Uterine Tone During Elective Caesarean Delivery: A Dose-Finding Study. BMC Pregnancy Childbirth 2020; 20:6.
Beiranvand S, Karimi A, Vahabi S, Amin-Bidokhti A . Comparison of the Mean Minimum Dose of Bolus Oxytocin
for Proper Uterine Contraction During Cesarean Section. Curr
Clin Pharmacol 2019; 14:208-213. 29. Shashikiran, Kaur H, Bala R, Gupta N. A study to determine
minimum effective dose of oxytocin infusion during caesarean delivery in parturients at high risk of uterine atony. J Obstet
Anaesth Crit Care 2017; 7:75-80.
Keikhaie KR, Behzadmehr R, Salarzaeis M. Comparison of Two Doses of Oxytocin Regimes to Prevent Post-Caesarean
Bleeding Due to Uterine Atony in Pregnant Women Referring to Amir-al Momenin Hospital of Zabol in 2016. Ann Med
Health Sci Res. 2017; 7:405-407.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Muhammad Salman Maqbool, Huda Shafqat, Ayesha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
